Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis
Published Online: 2020-06-02
Journal: Nature MedicineLoading...
Authors: Albert Kim•Anita Giobbie-Hurder•Beverly Moy•Brian Shaw•Brian V. Nahed•Christopher Alvarez-Breckenridge•Daniel P. Cahill•Deborah A. Forst•Donald Lawrence•Elizabeth R. Gerstner•Eudocia Quant Lee•Helen A. Shih•Ian Krop•Joana L. Mora•Jorg Dietrich•Justine V. Cohen•Kevin Oh•Lakshmi Nayak•Maura Keeley Mahar•Megha Subramanian•Mia S. Bertalan•Michael D. White•Naema Nayyar•Nancy U. Lin•Nancy Wang•Nathaniel Goss•Priscilla K. Brastianos•Ryan J. Sullivan•Sara M. Tolaney•Scott L. Carter•Tracy T. Batchelor•Ugonma Chukwueke
